Integrating echocardiographic parameters and novel biomarkers such as galectin-3 and pentraxin-3 in the assessment of heart failure severity

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Alexandru Oancea

Grigore T. Popa University of Medicine and Pharmacy, Iasi (Romania)

6 More presentations in this session

Presentation thumbnail

Higher intensity of guideline-directed medical therapy is independently associated with a more favourable biomarker profile in real-world heart failure patients

Doctor J. Dodulik (Ostrava, CZ)

Abstract Slides

Presentation thumbnail

Interplay between cholestasis and venous congestion: prognostic impact of alkaline phosphatase and CA125 in acute heart failure

Mr J. Rodriguez Oyuela (Madrid, ES)

Abstract Slides

Presentation thumbnail

Proteomic variations in circulating blood of heart failure patients according to iron status

Mr J. Francesch Manzano (Hospitalet de Llobregat, ES)

Abstract Slides

Presentation thumbnail

GDF-15 and heart failure readmissions: prognostic value in acute heart failure with reduced ejection fraction

Doctor A. Bollas Becerra (Madrid, ES)

Abstract Slides

Presentation thumbnail

Prognostic value of the glucose-potassium ratio and pulmonary capillary wedge pressure in patients with ischemic HFpEF

Doctor V. Lysenko (Zaporizhzhya, UA)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - biomarkers (1)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Session

From genetic signatures to clinical implications

Congress Presentation

A proteo-genomic discovery approach to identify markers of early heart failure

Congress Presentation

State-of-the-art lecture on current state of the diagnosis of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources